@phdthesis{Gloeckner2001,
  author    = {Gl{\"o}ckner, Herma},
  title     = {Characterization of a new miniaturized hollow-fiber bioreactor for cultivation of cell lines and primary cells to improve cytostatic drug testing in vitro},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-1181317},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2001},
  abstract  = {Monolayer or suspension cell cultures are of only limited value as experimental models for human cancer. Therefore, more sophisticated, three-dimensional culture systems like spheroid cultures or histocultures are used, which more closely mimic the tumor in individual patients compared to monolayer or suspension cultures. As tissue culture or tissue engineering requires more sophisticated culture, specialized in vitro techniques may also improve experimental tumor models. In the present work, a new miniaturized hollow-fiber bioreactor system for mammalian cell culture in small volumes (up to 3 ml) is characterized with regard to transport characteristics and growth of leukemic cell lines (chapter 2). Cell and medium compartment are separated by dialysis membranes and oxygenation is accomplished using oxygenation membranes. Due to a transparent housing, cells can be observed by microscopy during culture. The leukemic cell lines CCRF-CEM, HL-60 and REH were cultivated up to densities of 3.5 x 107/ml without medium change or manipulation of the cells. Growth and viability of the cells in the bioreactor were the same or better, and the viable cell count was always higher compared to culture in Transwell{\^a} plates. As shown using CCRF-CEM cells, growth in the bioreactor was strongly influenced and could be controlled by the medium flow rate. As a consequence, consumption of glucose and generation of lactate varied with the flow rate. Influx of low molecular weight substances in the cell compartment could be regulated by variation of the concentration in the medium compartment. Thus, time dependent concentration profiles (e.g. pharmacokinetic profiles of drugs) can be realized as illustrated using glucose as a model compound. Depending on the molecular size cut-off of the membranes used, added growth factors like GM-CSF and IL-3 as well as factors secreted from the cells are retained in the cell compartment for up to one week. Second, a method for monitoring cell proliferation the hollow-fiber bioreactor by use of the Alamar BlueTM dye was developed (chapter 3). Alamar BlueTM is a non-fluorescent compound which yields a fluorescent product after reduction e.g. by living cells. In contrast to the MTT-assay, the Alamar BlueTM-assay does not lead to cell death. However, when not removed from the cells, the Alamar BlueTM dye shows a reversible, time- and concentration-dependent growth inhibition as observed for leukemic cell lines. When applied in the medium compartment of a hollow-fiber bioreactor system, the dye is delivered to the cells across the hollow-fiber membrane, reduced by the cells and released from the cell into the medium compartment back again. Thus, fluorescence intensity can be measured in medium samples reflecting growth of the cells in the cell compartment. This procedure offers several advantages. First, exposure of the cells to the dye can be reduced compared to conventional culture in plates. Second, handling steps are minimized since no sample of the cells needs to be taken for readout. Moreover, for the exchange of medium, a centrifugation step can be avoided and the cells can be cultivated further. Third, the method allows to discriminate between cell densities of 105, 106 and 107 of proliferating HL-60 cells cultivated in the cell compartment of the bioreactor. Measurement of fluorescence in the medium compartment is more sensitive compared to glucose or lactate measurement for cell counts below 106 cells/ml, in particular. In conclusion, the Alamar BlueTM-assay combined with the hollow-fiber bioreactor offers distinct advantages for the non-invasive monitoring of cell viability and proliferation in a closed system. In chapter 4 the use of the hollow-fiber bioreactor as a tool for toxicity testing was investigated, as current models for toxicity as well as efficacy testing of drugs in vitro allow only limited conclusions with regard to the in vivo situation. Examples of the drawbacks of current test systems are the lack of realistic in vitro tumor models and difficulties to model drug pharmacokinetics. The bioreactor proved to be pyrogen free and is steam-sterilizable. Leukemic cell lines like HL-60 and primary cells such as PHA-stimulated lymphocytes can be grown up to high densities of 1-3 x 107 and analyzed during growth in the bioreactor by light-microscopy. The cytostatic drug Ara-C shows a dose-dependent growth inhibition of HL-60 cells and a dose-response curve similar to controls in culture plates. The bioreactor system is highly flexible since several systems can be run in parallel, soluble drugs can be delivered continuously via a perfusion membrane and gaseous compounds via an oxygenation membrane which also allows to control pO2 and pH (via pCO2) during culture in the cell compartment. The modular concept of the bioreactor system allows realization of a variety of different design properties, which may lead to an improved in vitro system for toxicity testing by more closely resembling the in vivo situation. Whereas several distinct advantages of the new system have been demonstrated, more work has to be done to promote in vitro systems in toxicity testing and drug development further and to reduce the need for animal tests.},
  subject      = {Hohlfaserreaktor},
  language  = {en}
}
@phdthesis{Tulke2020,
  author    = {Tulke, Moritz},
  title     = {Grundlegende Arbeiten zum bio-artifiziellen renalen Tubulus aus ko-kultivierten adipozyt{\"a}ren mesenchymalen Stammzellen und Endothelzellen auf einer synthetischen Kapillarmembran},
  doi       = {10.25972/OPUS-21689},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-216896},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2020},
  abstract  = {Mit fortschreitender chronischer Niereninsuffizienz kommt es zur Akkumulation von Ur{\"a}mietoxinen und im Endstadium unbehandelt zum Tod im sogenannten Ur{\"a}mischen Syndrom. Die Blutreinigung erfolgt bei der am h{\"a}ufigsten verwendeten Form der Nierenersatztherapie, der H{\"a}modialyse, nur unzureichend. Die Folge ist eine erh{\"o}hte Morbidit{\"a}t und Mortalit{\"a}t der betroffenen Patienten. Bei der H{\"a}modialyse werden nur Ur{\"a}mietoxine bis zu einer Gr{\"o}ße von 20 kDa {\"u}ber die im Dialysator eingesetzten Hohlfaserdialysemembranen diffusiv und konvektiv semiselektiv nach Gr{\"o}ßenausschluss entfernt. Proteingebundene Ur{\"a}mietoxine, deren effektive Gr{\"o}ße durch die Bindung an Transportproteine wie beispielsweise Albumin die Trennsch{\"a}rfe der Dialysemembranen {\"u}bersteigt, werden retiniert. In-vivo werden proteingebundene Ur{\"a}mietoxine im proximalen Tubulus, einem Teil des tubul{\"a}ren Systems des Nephrons, sekretorisch eliminiert. Im Rahmen der vorliegenden Promotionsarbeit wurden die ersten Entwicklungsschritte auf dem Weg zu einem sogenannten bio-artifiziellen Tubulus evaluiert. Der angedachte biohybride Filter sollte aus einer Ko-Kultur funktionaler humaner proximaler Tubuluszellen und humaner Endothelzellen (HUVEC) auf synthetischen Hohlfasermembranen bestehen und k{\"o}nnte w{\"a}hrend der H{\"a}modialyse als zus{\"a}tzlicher Reinigungsschritt angewendet werden, um unter anderem proteingebundene Ur{\"a}mietoxine effektiv durch aktiven Transport aus dem Blut der Patienten zu entfernen. Die Differenzierung der proximalen Tubuluszellen erfolgte dabei aus adulten adipozyt{\"a}ren mesenchymalen Stammzellen (ASC), deren Herkunft eine sp{\"a}tere autologe Behandlung erm{\"o}glicht. Die Ko-Kultur mit Endothelzellen wurde zur potentiellen Steigerung der Sekretion proteingebundener Ur{\"a}mietoxine verwendet. In der vorliegenden Arbeit konnten ASCs durch eine Kombination der l{\"o}slichen Differenzierungsfaktoren All-Trans-Retinoins{\"a}ure (ATRA), Aktivin A und BMP-7 erfolgreich in Zytokeratin 18-exprimierende Zellen differenziert werden, wodurch die erw{\"u}nschte epitheliale Differenzierung best{\"a}tigt wurde. Die Expression funktionaler Proteine, wie das f{\"u}r den Wassertransport relevante Aquaporin 1 oder auch der Na+-/K+-ATPase, konnte in dieser Arbeit bereits vor der Differenzierung nachgewiesen werden. Im n{\"a}chsten Schritt wurde erfolgreich gezeigt, dass eine simultane, qualitativ hochwertige Ko-Kultur von ASCs und HUVECs auf der mit dem extrazellul{\"a}ren Matrixprotein Fibronektin modifizierten Innen- bzw. Außenseite von synthetischen Hohlfasermembranen aus Polypropylen bzw. Polyethersulfon m{\"o}glich ist. Die Viabilit{\"a}t beider Zelltypen wurde dabei durch die Verwendung eines f{\"u}r die Ko-Kultur entwickelten N{\"a}hrmediums erreicht, in welchem die Proliferation von ASCs bei gleichzeitiger Aufrechterhaltung ihrer Stammzelleigenschaften deutlich erh{\"o}ht war. Die in dieser Arbeit erzielten Ergebnisse stellen eine aussichtsreiche Basis f{\"u}r einen bio-artifiziellen renalen Tubulus dar. Weitere Entwicklungsschritte, wie die Differenzierung der ASCs zu proximalen Tubuluszellen im 3D-Bioreaktor einschließlich ihrer funktionalen Charakterisierung anhand Tubulusepithel-spezifischer Transporter, sind erforderlich, be-vor erste funktionale Experimente vor dem „Upscaling" auf klinisch verwendbare Module m{\"o}glich sind.},
  subject      = {Hohlfaserreaktor},
  language  = {de}
}